Astellas/Cardiome Anticipate Oct. 19 Vernakalant User Fee Date
This article was originally published in The Pink Sheet Daily
Executive Summary
Astellas’ resubmission of the atrial fibrillation agent’s NDA triggers a $10 million milestone payment to Cardiome.